Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05389332 · ClinicalTrials.gov registry record · NA
A Mobile Health Intervention Among Hispanics
A NA study of Cancer of Skin, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- NA
- Development phase
- 114
- Enrollment target
- 1
- Study location
NCT05389332: Recruiting NA study of Cancer of Skin, sponsored by Rutgers, The State University of New Jersey.
NCT05389332 is a NA study of Cancer of Skin that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 114 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05389332, a NA study of Cancer of Skin, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypothesis: More than 80% of the participants (n=40) will complete the intervention at three month (intervention completion) and the six month follow-up (retention rate as feasibility). More than 70% of the participants will report high overall study satisfaction (acceptability) with the intervention and study. This pre-pilot will inform intervention and procedural refinements for the pilot. Hypothesis: Participants who receive the intervention (n=57) will report more skin cancer-related preventive behaviors (e.g., mean of summed score of sun protection behaviors such as use of sunscreen, etc.) at three month and six month follow-up compared to those in the control condition (n=57, who will receive general information about physical activity and nutrition).
Primary Outcome
Mean score of use sunscreen with an SPF 30 or higher, seek shade, wear protective clothing, wear wide-brimmed hat, wear sunglasses
Conditions Studied
Interventions
- BEHAVIORAL Hispanics Skin Cancer intervention
- BEHAVIORAL Control group: physical activity and nutrition for Hispanics
Study Locations (1)
New Jersey
- Rutgers Cancer Institute of New Jersey - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2025-04-20 |
| Est. Completion | 2026-10-31 |
| Phase | NA |
What NCT05389332 shows while recruiting
NCT05389332 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Cancer of Skin appearing as the primary indexed condition, and to 2 interventions - of which Hispanics Skin Cancer intervention is the first listed.
NCT05389332 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT05389332 about?
NCT05389332 is a clinical study titled "A Mobile Health Intervention Among Hispanics". Hypothesis: More than 80% of the participants (n=40) will complete the intervention at three month (intervention completion) and the six month follow-up (retention rate as feasibility). More than 70% of the participants will report high overall study satisfaction (acceptability) with the interventio...
What is the current status of trial NCT05389332?
This trial is currently recruiting. It is a NA study. The enrollment target is 114 participants. The study started on 2025-04-20. Estimated completion is 2026-10-31.
What conditions does trial NCT05389332 study?
This clinical trial studies the following conditions: Cancer of Skin.
What interventions are being tested in trial NCT05389332?
The interventions under investigation include: Hispanics Skin Cancer intervention (BEHAVIORAL), Control group: physical activity and nutrition for Hispanics (BEHAVIORAL).
Who is sponsoring clinical trial NCT05389332?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05389332 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05389332's enrollment target sits among peer trials
114 811th of 2000 higher than 1,188 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI